BackCoeptis Therapeutics Holdings- Warrants (31/10/2025) Overview

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Current Assets

Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s current assets is $5.9M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$5.91M
27.03% YoYΔ $1.26M vs prior year quarter

Peer average

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Current Assets History

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) vs. peers: Current Assets Comparison

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) (COEPW) FAQ

Coeptis Therapeutics Holdings- Warrants (31/10/2025) (COEPW) currently reports a current assets of $5.9M as of March 2026. That compares with $4.7M in the prior-year period — up 27.0% year over year. Use the charts on this page to explore Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s current assets history and peer comparisons.

Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s current assets increased from $4.7M to $5.9M — a 27.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Coeptis Therapeutics Holdings- Warrants (31/10/2025) reported $5.9M in current assets as of March 2026. That compares with $4.7M in the prior-year period — up 27.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $5.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Coeptis Therapeutics Holdings- Warrants (31/10/2025), and consider following COEPW for alerts when major investors trade the stock.